Xcout Intel
FogPharma
FogPharma, also known as Parabilis Medicines, is a clinical-stage biopharmaceutical and biotechnology research company headquartered in Cambridge, Massachusetts. The company is dedicated to creating novel therapeutics.
Subscribe to see FogPharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FogPharma at a glance
FogPharma is a biotech company headquartered in United States. Xcout tracks 14 named people at FogPharma, including Mathai Mammen (Chairman, CEO and President). Xcout recorded 1 job posting from FogPharma in the last 90 days.
FogPharma leadership
- Mathai MammenChairman, CEO and President
- Thomas KotarakosChief Financial Officer
- Fawzi BenzaghouChief Medical Officer
- Helen HoChief Business and Strategy Officer
- Kristen StantsChief People Officer
- Rohin MhatreChief Technical Operations Officer
8 more named people on record for FogPharma, with roles, board committees and tenure — see the full roster →
Hiring at FogPharma
Xcout recorded 1 job posting from FogPharma in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see FogPharma's hiring signals →
FogPharma competitors
A few of FogPharma's closest competitors — see the full list of competitors and alternatives →
Parabilis Medicines is a biopharmaceutical company that develops ultra-tunable peptide therapeutics utilizing its proprietary Helicon platform. The company focuses on creating novel medicines to target historically undruggable conditions, primarily addressing cancer and other serious diseases with critical medical needs.
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
Kinaset Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel therapeutics.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Notable Labs, Inc. is a clinical-stage therapeutic platform company headquartered in Foster City, California. The company focuses on drug pipelines, patents, and clinical trials, and operates as a public company traded on NASDAQ under the ticker NTBL.
Get FogPharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on FogPharma in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access